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Alterations to the microbiota-colon-brain axis in high-fat-diet-induced obese mice 
compared to diet-resistant mice 
Abstract 
Obesity is underpinned by both genetic and environmental factors, including a high-saturated-fat diet. 
Some mice develop diet-induced obesity (DIO), but others remain diet resistant (DR) despite intake of the 
same high-saturated-fat diet, a phenomenon that mimics characteristics of the human obese phenotype. 
Microbiota-colon-brain axis regulation is important for energy metabolism and cognition. Using DIO and 
DR mouse models, this study aimed to examine gut microbiota, colonic inflammation and cognitive 
function to elucidate the role of microbiota-gut-brain regulation in DIO. C57Bl6/J mice fed a chronic 
saturated-palmitic-acid diet for 22 weeks showed significant body weight gain differences, with the top 
one third gaining 48% heavier body weight than the lower one third. There was significant reduction in gut 
microbiota richness and diversity in DIO mice but not in DR mice. At the phylum level, DIO mice had 
increased abundance of Firmicutes and Antinobacteria, and decreased abundance of Bacterioides and 
Proteobacteria in gut microbiota. DIO mice exhibited reduced tight junction proteins, increased plasma 
endotoxin lipopolysaccharide (LPS) and increased inflammation in the colon and liver. Recognition 
memory and spatial memory were impaired in DIO mice, associated with decreased Bacteroidetes. 
Further examination showed that hippocampal brain-derived neurotrophic factor was significantly 
decreased in DIO mice (vs. DR). Conversely, DR mice showed no changes in the above parameters 
measured. Therefore, gut microbiota, colon inflammation and circulating LPS may play a major role in the 
development of the obese phenotype and cognitive decline associated with a chronic high-saturated-
palmitic-acid diet. 
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Abstract: 
Obesity is underpinned by both genetic and environmental factors, including a high 
saturated fat diet. Some mice develop diet-induced obesity (DIO) but others remain 
diet-resistant (DR), despite intake of the same high-saturated fat diet; a phenomenon 
that mimics characteristics of the human obese phenotype. Microbiota-colon-brain 
axis regulation is important for energy metabolism and cognition. Using DIO and DR 
mouse models, this study aimed to examine gut microbiota, colonic inflammation and 
cognitive function to elucidate the role of microbiota-gut-brain regulation in 
diet-induced obesity. C57Bl6/J mice fed a chronic saturated palmitic acid diet for 22 
weeks showed significant body weight gain differences, with the top one third gaining 
48% heavier body weight than the lower one third. There was significant reduction in 
gut microbiota richness and diversity in DIO mice, but not in DR mice. At the phylum 
level, DIO mice had increased abundance of Firmicutes and Antinobacteria, and 
decreased abundance of Bacterioides and Proteobacteria in gut microbiota. DIO mice 
exhibited reduced tight junction proteins, increased plasma endotoxin 
lipopolysaccharide (LPS) and increased inflammation in the colon and liver. 
Recognition memory and spatial memory were impaired in DIO mice, associated with 
decreased Bacteroidetes. Further examination showed that hippocampal brain-derived 
neurotrophic factor (BDNF) was significantly decreased in DIO mice (vs DR). 
Conversely, DR mice showed no changes in the above parameters measured. 
Therefore, gut microbiota, colon inflammation and circulating LPS may play a major 
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role in the development of the obese phenotype and cognitive decline associated with 
a chronic high saturated palmitic acid diet.  
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1 INTRODUCTION: 
Diets rich in saturated fat can induce obesity, associated with insulin resistance and 
cognitive decline. Palmitic acid (PA, C16:0) is the most common saturated fatty acid 
in human diets in the modern society, accounting for approximately 65% of saturated 
fatty acids and 32% of total fatty acids in human serum [1]. Patients with metabolic 
syndrome have a significantly higher level of PA, but not other saturated fatty acids, 
such as myristic acid or stearic acid within erythrocytes [2]. Obesity is a polygenic 
disorder and results from a complex interaction with an obesogenic environment, 
including saturated fat intake [3]. For example, mice or rats fed a high-fat diet either 
develop obesity or resistance to obesity, but have comparable body weight when fed a 
lab chow diet [4-7]. Interestingly, there are differences in gene expression between 
diet-induced obesity (DIO) mice and their diet-resistant (DR) counterparts [8, 9], 
showing clear genetic distinction between resistant and non-resistant rodents. 
Therefore, DIO and DR models mimic some characteristics of the human obese 
phenotype, including a polygenic mode of inheritance and the fact that some (but not 
all) individuals are susceptible to weight gain when exposed to an obesogenic 
environment [10].  
The role of gut microbiota in contributing to obesity has been recognized. For 
example, an imbalance of Firmicutes and Bacteroidetes, the primary bacterial phyla 
comprising the gastrointestinal microbiota, has been reported in the leptin-deficient 
ob/ob mouse model [10, 11]. Consistent with animal studies, similar differences with 
an increase in the ratio of Firmicutes/Bacteroidetes has been found in the distal gut 
 6
microbiota in obese individuals [12]. However, alterations in the gut microbiota in 
obese individuals have not been reported by all investigators [13]. It has even been 
reported that ratios of Firmicutes to Bacteroidetes are lower in some obese adults 
compared to lean controls [14], whereas a study employing an 8-week high-saturated 
fat diet altered gut microbiota with increased Firmicutes and reduced Bacteriodetes in 
mice [15]. However, rare studies have examined microbiota in obesity in a manner 
that encompasses the interaction between environmental and genetic factors using 
DIO compared to DR phenotypes.  
Obesity has been associated with a chronic low-grade level of inflammation. 
Alterations in the gut microbiota may play a role in intestinal inflammation and 
epithelial functions in the development of obesity. High-fat dietary intake increases 
circulating plasma levels of lipopolysaccharide (LPS, endotoxin), a breakdown 
product of outer layer of Gram-negative bacteria [16]. LPS and saturated fatty acids 
exert effects on the toll-like receptor 4 (TLR4) [17], which is expressed at high levels 
in the colon, but lower levels in the small intestine [18, 19]. TLR4 and its adaptor 
protein, myeloid differentiation primary-response protein 88 (MyD88), activate the 
inflammatory signaling pathway, including inhibitor kappa B alpha (IκBα) and 
nuclear factor-kappa B (NFκB) [20]. In addition, intestinal macrophages are essential 
for intestinal homeostasis and play critical roles in protective immunity and 
inflammation [21, 22]. The colon has a high density of macrophages compared to 
other parts of the gastrointestinal tract [23]. In the healthy mouse colon, most resident 
macrophages are resistant to TLR stimulation and express anti-inflammatory markers, 
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such as CD206, to prevent inflammation [24]. On the other hand, experimental colitis 
results in the accumulation of TLR-responsive pro-inflammatory macrophages, most 
of which become CD11c+ and F4/80+, indicating upregulated pro-inflammatory 
actions [24]. A recent report showed that colonic pro-inflammatory macrophages play 
a causal role in the development of insulin resistance, as decreased infiltration of 
colonic pro-inflammatory macrophages improved high-fat diet-induced insulin 
resistance in macrophage-specific chemokine (C-CMotif) receptor 2 (Ccr2) knockout 
(M-Ccr2KO) mice [25]. Another study found that the switch from anti-inflammatory 
to pro-inflammatory macrophages occurred in adipose and muscle tissue, as well as 
the liver and pancreas, contributing to insulin resistance in obesity [26]. However, the 
status of macrophages in the colon of DIO and DR mice requires further investigation. 
Furthermore, the role of colonic inflammation in generating obesity induced by a high 
saturated fat diet and altered gut microbiota is unknown. 
Evidence shows a link between gut microbiota, central levels of brain-derived 
neurotrophic factor (BDNF) and cognitive behavior. For example, one study showed 
that administration of gut bacteria Citrobacter rodentium by oral gavage caused 
memory dysfunction in mice exposed to stress conditions  [27], while another 
reported that oral antimicrobial treatment transiently altered the composition of the 
microbiota and increased hippocampal BDNF expression [28]. On the other hand, 
reduced BDNF expression in the hippocampus contributes to working-memory 
impairment in germ-free mice [27]. These studies suggest that BDNF may be 
influenced by gut microbiota, causing effects on cognitive function. However, it is not 
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known whether cognition and altered BDNF levels are affected by a diet high in 
saturated palmitic acid or by the presence of obesity, and whether alterations in these 
factors occur concurrently with altered gut microbiota. 
A useful tool in preclinical obesity research to study the interaction between diet 
and genes is the C57 male mouse model, incorporating mice genetically prone to 
diet-induced obesity and their diet-resistant counterparts. When exposed to a high-fat 
diet, the DIO mice gain weight and become obese, while the DR mice remain as lean 
as the control mice. Therefore, the DIO and DR mouse model can provide insight into 
whether changes in the gut microbiota, colon inflammation and cognition are driven 
by the high saturated PA diet or by the ensuing obesity. In the current study, by using 
both chow- and PA diet-fed DIO and DR mice, we determined whether shifts in the 
microbiota profile result solely from the consumption of an obesogenic PA diet or are 
a manifestation of the obese phenotype. Furthermore, we examined levels of LPS (an 
endotoxin) in plasma, colonic tight junction protein levels (reflecting the permeability 
of colon epithelia), macrophage shifting towards a pro-inflammatory phenotype and 
markers of inflammation in the colon, as well as hippocampal BDNF and cognitive 
behavior.  
 
2 MATERIALS AND METHODS: 
2.1 Animals and treatments 
Seventy-two C57Bl/6J male mice (6 weeks old) were obtained from the Animal 
Resources Center (Perth, WA, Australia). They were housed in environmentally 
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controlled conditions (temperature 22°C, 12 hour light/dark cycle), and allowed ad 
libitum access to food and water through-out the study. Mice were fed standard 
laboratory chow (ie low fat (LF) diet, AIN93M, Speciality Feeds, WA, Australia) for 
the first week to facilitate habituation to the new environment, then randomized into 
dietary treatment groups. The first group of mice (n=18) was fed a LF diet as a 
control, while the second group (n=54) was fed a high PA diet for 22 weeks. High PA 
diets were custom-made by Specialty Feeds (SF15-080, WA Australia) and contained 
300 g/kg as fat (30%), including 100 g/kg palmitate (ie palmitate equivalent to 30% of 
total fat composition). The rationale for choosing this lipid composition was based on 
the average saturated fat content of a hamburger (ie a typical modern Western human 
fast food meal item), which can be more than 30%. The LF diet was used as a control, 
with a crude fat content of 4% (PA, 0.008%). After consuming the high PA diet for 
8-weeks, the mice with the highest body weight gain were designated as the DIO mice 
(n=18), while mice with the lowest body weight gain were designated as the DR mice 
(n=18), according to methods we have previously published [29, 30] Mice with an 
intermediate body weight gain were removed from this study.  
After 19 weeks of consuming either a high PA or LF diet, mice underwent an 
intraperitoneal glucose tolerance test (IPGTT, Section 2.2 below), followed by a 
series of behavioural tests in weeks 20-21 (Section 2.3). Mice were sacrificed after 
22-weeks of dietary treatment, 4 days after behavioural testing. Four fat pads (Inguinal, 
Epididymal, Perirenal, Mesenteric) were excised and weighed. Each group of mice 
(n=18) were further divided into 3 subgroups (n=6) for tissue examination: 
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immunohistochemistry in colon and liver after fixing tissue; Western blot in colon and 
liver; In situ in brain and microbial diversity analysis in cecal content. Samples of 
plasma, intestine and cecal content, as well as liver and brain tissues were collected 
and stored at -80 °C for further analyses. All experimental procedures were approved 
by the Animal Ethics Committee, University of Wollongong, Australia, and all animal 
experiments were conducted in compliance with National Health and Medical 
Research Council (NHMRC) Australian Code of Practice for the Care and Use of 
Animal for Scientific Purposes (2004).  
 
2.2 Intraperitoneal glucose tolerance test (IPGTT) 
The IPGTT was conducted as we have previously described [31]. Briefly mice 
were fasted overnight followed by an intraperitoneal injection of glucose (0.5 g/kg; 
Sigma-Aldrich, St Louis, MO, USA). Blood samples were obtained from the tail vein 
at 0, 30, 60 and 120 minutes following the injection of glucose. Blood glucose levels 
were measured in duplicate using an Accu-Chek glucometer (Roche Diagnostics 
GmbH Mannheim, Germany). 
 
2.3 Behavioral tests 
The Y-maze and novel object recognition tests were performed in order to 
examine dietary effects on spatial and recognition memory. Tests were conducted 
based on methods previously published [32, 33] (see Supporting Information for 
detailed methods). In the Y-maze test, the ratio of time spent in the novel arm (a 
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ratio of the amount of time spent in the novel arm over the total time spent in all 
three arms) was used to evaluate spatial memory. For the novel object recognition 
test, the discrimination index ([(Novel object exploration time/Total exploration 
time)−(Familiar object exploration time/Total exploration time)]×100) was used to 
evaluate recognition memory. 
 
2.4 Plasma leptin and adiponectin 
Post-mortem blood was collected directly from the heart into a heparin coated tube. 
Blood samples were centrifuged at 4000rpm for 10 minutes (4
o
C) and plasma was 
collected. Using the mouse endocrine Lincoplex kit (Cat.# MENDO-75K, Linco 
Research, St Louis, MO, USA), the plasma levels of leptin and adiponectin were 
determined.  
 
2.5 Haematoxylin and eosin (H & E) staining  
Paraffin-embedded liver sections (5µm) were stained with hematoxylin and eosin. 
The histological parameters (steatosis and ballooning) were scored using a method 






The immunohistochemical staining method for liver or colon sections was 
conducted using the protocol we have previously published [34] (see Supporting 
Information for detailed methods).  
 
2.7 Western blotting 
Colon tissues were dissected and homogenized in a NP-40 lysis buffer (containing 
NP40, Protease Inhibitor Cocktail, 1 mM PMSF and 0.5 mM β -glycerophosphate). 
Total protein concentrations were determined by DC-Assay (Bio-Rad, Hercules, CA) 
and detected using a SpectraMax Plus384 absorbance microplate reader (Molecular 
Devices, Sunnyvale, CA). The Western blot method was conducted as described in 
our previous study [35] (see Supporting Information for detailed methods). 
 
2.8 Lipopolysaccharide (LPS) determination 
The concentration of circulating plasma LPS was measured by enzyme-linked 
immunosorbent assay (LAL assay kit, Hycult Biotech, The Netherlands). The 
absorbance was measured at 405 nm using a spectrophotometer, with measurable 
concentrations ranging from 0.04 to 10 EU/ml. All samples for LPS measurements 
were performed in duplicate. 
 
2.9 Microbial diversity analysis 
2.9.1 DNA extraction and PCR amplification 
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Microbial DNA was extracted from cecal content using the E.Z.N.A.® stool DNA 
Kit (Omega Bio-tek, Norcross, GA, U.S.) according to manufacturer’s protocols. The 
V4-V5 regions of the bacteria 16S ribosomal RNA gene were amplified by PCR (95 
°C for 2 min, followed by 25 cycles at 95 °C for 30 s, 55 °C for 30 s, and 72 °C for 
45 s with a final extension at 72 °C for 5 min) using primers 338F 5’-barcode- 
ACTCCTACGGGAGGCAGCAG)-3’ and 806R 
5’-GGACTACHVGGGTWTCTAAT-3’, where the barcode was an eight-base 
sequence unique to each sample. PCR reactions were performed in triplicate with 
20 µL mixture containing 4 µL of 5 × FastPfu Buffer, 2 µL of 2.5 mM dNTPs, 0.8 µL 
of each primer (5 µM), 0.4 µL of FastPfu Polymerase, and 10 ng of template DNA. 
 
2.9.2 Illumina MiSeq sequencing  
Amplicons were extracted from 2% agarose gels and purified using the AxyPrep 
DNA Gel Extraction Kit (Axygen Biosciences, Union City, CA, USA) according to 
the manufacturer’s instructions and quantified using QuantiFluor™ -ST (Promega, 
U.S.). Purified amplicons were pooled in equimolar and paired-end sequenced (2 × 
250) on an Illumina MiSeq platform according to standard protocols.  
 
2.9.3 Processing of sequencing data 
Raw fastq files were demultiplexed, quality-filtered using QIIME (version 1.17) 
with the following criteria: (i) The 300 bp reads were truncated at any site receiving 
an average quality score <20 over a 50 bp sliding window, discarding the truncated 
reads that were shorter than 50bp. (ii) exact barcode matching, 2 nucleotide mismatch 
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in primer matching, reads containing ambiguous characters were removed. (iii) only 
sequences that overlap longer than 10 bp were assembled according to their overlap 
sequence. Readings that could not be assembled were discarded.  
Operational Units (OTUs) were clustered with 97% similarity cut-off using 
UPARSE (version 7.1 http://drive5.com/uparse/) and chimeric sequences were 
identified and removed using UCHIME. The taxonomy of each 16S rRNA gene 
sequence was analyzed by RDP Classifier (http://rdp.cme.msu.edu/) against the silva 
(SSU115)16S rRNA database using confidence threshold of 70%. 
 
2.10 In situ hybridization 
Coronal brain sections (14 µm) sections were collected from Bregma +0.14mm to 
-2.92mm according to a standard mouse brain atlas [36]. The hybridization 
procedures and mRNA quantification were described in our previous study [37] (see 
Supporting Information for detailed methods). 
 
2.11 Statistical analysis 
Data were analyzed using the statistical package SPSS (version 20, IBM 
Corporation, Chicago, IL, USA). Data was first tested for normality before 
differences among the DIO, DR and LC groups were determined using one-way 
analysis of variance (ANOVA). This was followed by the post hoc Tukey-Kramer 
honestly significant difference (HSD) test for multiple comparisons among the 
groups. A p value of <0.05 was considered to be statistically significant. Values were 
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expressed as mean ± SEM. Pearson’s correlations were used to examine the 
relationships between the parameters in the behavior tests and Bacteroidetes as well as 




3.1 Chronic PA diet increased body weight, adiposity, food intake, and hepatic 
injury in DIO mice  
On a chronic high PA diet, the DIO mice gained significantly more body weight 
than the DR and LF mice from 5 weeks and this persisted throughout the rest of the 
dietary intervention (Fig. 1A). The final body weight of DIO mice was 48% and 54% 
heavier than that of DR and LF mice (both P < .01) (Fig. 1B). Moreover, DIO mice 
consumed significantly more calories compared to the DR (P < .05) and LF mice (P 
< .05) (Fig. 1C). The DIO mice had higher inguinal, epididymal, perirenal and 
mesenteric fat masses compared to DR and LF mice (Fig. 1D). Furthermore, the DIO 
mice also had higher fat ratios after normalized to body weight (Fig. 1E). The IPGTT 
revealed that the DIO mice had an impaired glucose tolerance (Fig. 1F). The blood 
glucose levels of DIO mice significantly increased at 0, 15, 30, 60, and 120 minutes 
during the IPGTT compared to the DR and LF mice (All P < .05). Leptin and 
adiponectin are secreted from adipose tissue and have anti-obesity effects [38], but the 
DIO mice exhibited hyperleptinemia and a low ratio of plasma adiponectin to visceral 
fat (Fig. 1G-I), suggesting leptin resistance and impaired secretion of adiponectin in 
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these mice. Therefore, even though the DIO and DR mice were exposed to the same 
obesogenic diet and housed under the same conditions, the results suggest some 
genetic variations that contribute to the susceptibility of gaining weight on a high 
saturated-fat diet. 
 
3.2 Chronic PA diet-induced DIO and DR mice have different gut microbiota 
profiles  
Bacterial communities within the feces were determined by Illumina MiSeq 
sequencing of 16S rRNA genes and resulted in the recovery of 1604,201 effective 
sequences with a read length ≥ 360 bp. After quality filtering by QIIME, 1497,652 
high-quality reads were obtained, accounting for 93.36% of the raw reads.  
Out of the 318 bacterial species-level operational taxonomic units (OTUs) found in 
this study, 295 were found in LF and DR mice; only 272 were found in DIO mice. 
There were 252 OTUs shared by LF, DR and DIO groups. There were 23 OTUs 
shared by LF and DR mice, while there were only 6 OTUs shared by LF and DIO 
mice and 11 OTUs shared by DIO and DR mice (Fig. 2A). Furthermore, DIO mice 
had lower species richness than DR and LF mice [Chao 1 index (OTUs), DIO: 
176.75±10.18, DR: 203.10±11.04; LF: 210.45±11.31, P < .05)]; and had lower 
species diversity than that of DR and LF mice [Shannon index (OTUs), DIO: 3.05 ± 
0.34; DR: 4.07 ± 0.38; LF: 4.05 ± 0.37, P < .05] (Fig 2B). There was no significant 
difference in Chao1 and Shannon indices between LF and DR mice. 
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At the phyla level, the abundance of Firmicutes was higher in DIO mice compared 
to DR and LF mice (P < .05, Fig 2C), while there was no significant difference 
between DR and LF mice. The abundance of Bacteroidetes was lower in DIO and DR 
mice compared with LF mice, while DIO mice had a lower abundance than that of DR 
mice (P < .05, Fig 2C), suggesting that Bacteroidetes was not only decreased in 
obesity, also decreased by HF diet in DR mice without significant body weight gain. 
Similarly, the ratio of Firmicutes to Bacteroidetes in DIO mice and DR mice was 
significantly higher than LF mice (both P < .05, Fig 2D), while the DIO mice had the 
highest ratio. The abundance of Antinobacteria in DIO mice and DR mice were 
significantly higher than that of LF mice (both P < .05, Fig 2E) with the highest level 
in DIO mice. The abundance of Proteobacteria was lower in DIO group, but higher in 
the DR group compared to that of the LF group (both P < .05, Fig 2E).  
When comparing the microbiota of DIO, DR and LF mice using LDA effect size 
(LEfSe) calculation, we found 30 differentially abundant taxonomic classes (P < .05) 
with an LDA score higher than 2.0 (Fig 2F). The results showed that phylum 
Actinobacteria, class Actinobacteria, order Bifidobacteriales, family 
Bifidobacteriaceae and genus Bifidobacterium were all significantly increased in DIO 
mice. Notably, bacteria belonging to order Clostridiales 
Ruminococcaceae_nk4a214_group, Family_XIII_AD3011_group and Family_XIII 
were increased significantly in DR mice and an unidentified genus of family 
Erysipelotrichaceae was also increased significantly in DR mice (P < .05, Fig 2F). 
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3.3 Chronic PA diet altered colonic tight junction protein expression and 
induced hyperendotoxinemia in DIO, but not DR mice. 
To further determine whether changes in the gut microbiota could be associated 
with the epithelial permeability and systemic inflammation, we measured levels of 
tight junction protein expression and the plasma concentration of LPS, a trigger of 
inflammation. The epithelial cells in the colon are tightly bound by intercellular 
junctional protein complexes, occludin and zonula occludens (ZO-1), which regulate 
paracellular permeability and are crucial for the integrity of the epithelial barrier [39]. 
Both occludin and ZO-1 expression decreased significantly in the colon of DIO mice 
compared to DR and LF mice (all P < .01; Fig. 3A and B). Next, we found that the 
level of serum LPS significantly increased in DIO mice compared to DR and LF mice 
(both P < .01; Fig. 3C). There were significant negative associations between levels 
of serum LPS and the concentrations of occludin (r = -0.631, p = 0.005) and ZO-1 (r = 
-0.929, P < .001) (Fig. 3D and E), suggesting hyperendotoxinemia in DIO mice was 
associated with impaired tight junction in the colon. 
 
3.4 Chronic PA diet induced inflammation in the colon of DIO but not DR mice. 
It is known that inflammation increases intestinal epithelial tight junction 
permeability [40]. As levels of tight junction protein expression was reduced in the 
DIO mice in the present study, we further examined macrophage infiltration and 
inflammatory response in the colon of these mice. The positive immunoreactivity of 
F4/80 was significantly increased in the colon of DIO mice compared to DR and LF 
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mice (both p <0.01; Fig. 4A and B). Furthermore, we characterized the type of 
macrophages present. CD11c was used to detect M1 macrophages, which produce 
pro-inflammatory cytokines, and CD206 was used to detect M2 macrophages, which 
produce anti-inflammatory cytokines. The DIO mice had increased CD11c positive 
staining in the colon compared to DR and LF mice (both p <0.05; Fig. 4 A and C). 
There was no significant difference in CD206 staining among the DIO, DR and LF 
mice (Fig. 4 A and D). This indicates that the high PA diet promotes a shift in a 
pro-inflammatory M1 polarization in the colon of obese mice. 
As the pro-inflammatory M1 macrophage is TLR4-responsive and often associated 
with low grade inflammation in local tissue, we measured the expression of TLR4 and 
its adaptor protein, MyD88, as well as downstream signaling molecules (NFκB, IκBα 
and pIκBα) and pro-inflammatory cytokines (tumor necrosis factor-α (TNF-α), 
interleukin-1β (IL-1β) and interleukin-6 (IL-6)) in the colon by Western blotting. The 
levels of TLR4 and MyD88 were higher in DIO mice than that of DR and LF mice 
(all p <0.05; Fig. 4E and G). NFκB and pIκBα significantly increased in DIO mice 
compared to DR and LF mice, while IκBa decreased in the colon of DIO mice. The 
levels pro-inflammatory cytokines, TNFα, IL-1β and IL-6, were higher in DIO mice 
than the DR and LF mice (all P < .05; Fig. 4F and H). In the colon tissue, the level of 
cyclooxygenase isoform 2 (COX-2, a pro-inflammatory marker implicated in 
colorectal cancer progression [41]) was increased in DIO mice, but not DR mice 
compared to LF mice (both P < .05; Fig. 4F and H). 
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3.5 Chronic PA diet induced hepatic inflammation in the DIO but not DR mice. 
It has been reported that LPS binds to LPS-binding proteins in the liver, which then 
facilitate its transfer to CD14 receptors on the surface of the macrophages and activate 
the TLR4 signaling pathway [42]. Therefore, we examined hepatic pro-inflammatory 
signaling molecules in the DIO and DR mice. Firstly, the liver weight was heavier in 
DIO mice compared to DR and LF mice (both P < .01; Fig. 5A and B), and the ratio 
of liver weight to body weight was higher in DIO mice compared to DR and LF mice 
(both P < .05; Fig. 5C). Furthermore, At a histological level, the diagnostic criteria 
for hepatic steatosis includes the presence of steatosis and ballooning [43]. H & E 
staining revealed that the hepatocytes of DIO mice were enlarged and contained large 
cytoplasmic lipid droplets compared to the DR group (ballooning: + 274%, P < .001; 
steatosis: + 361%, P < .001) and LF mice (ballooning: + 319%, P < .001; steatosis: + 
391%, P < .001) (Fig. 5D and E). Moreover, the levels of TLR4, MyD88 and NFκB 
(inflammatory signaling molecules) were increased in the liver of DIO mice 
compared to DR and LF mice, while there was no significant difference between DR 
and LF mice (Fig. 5F and G). Therefore, DIO mice exhibited hepatic inflammation 
and steatosis, symptoms reportedly associated with insulin resistance and glucose 
intolerance [44]; the latter of which was also observed in these mice (see Section 3.1). 
 
3.6 Chronic PA diet impaired cognitive function in DIO mice and reduced 
hippocampal BDNF expression 
Studies show that cognition and BDNF levels are affected by alterations to gut 
microbiota [27, 28]. Therefore, we examined recognition and spatial memory, and 
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hippocampal BDNF levels in DIO mice (ie in the presence of concurrent altered gut 
microbiota). In the Y maze test, spatial memory was impaired in DIO mice, who 
showed a significant reduction in the ratio of time spent in the novel arm compared to 
the LF and DR mice (both P < .05; Fig. 6A). In novel object recognition test, the DIO 
mice showed a significant reduction in the discrimination index compared with LF 
and DR mice (both P < .01; Fig. 6B), suggesting the impairment of recognition 
memory. Recent studies have demonstrated a clear association between changes in 
microbiota and cognitive behavior [45]. Here, the Pearson’s correlation analysis 
revealed a significant positive correlation between the abundance of Bacteroidetes and 
cognitive behavior, including the ratio of time spent in novel arm (r = 0.65, p = 0.003) 
and discrimination index (r =0.80, P < .001) (Fig. 6C and D). Next, in-situ 
hybridization was used to examine the level of hippocampal BDNF mRNA 
expression, which is implicated in spatial and recognition memory. The level of 
BDNF mRNA expression was significantly decreased in the hippocampus, including 
the CA1-3 and DG regions, in DIO mice compared to DR and LF mice (P < .05; Fig. 
6E and F).  
 
4 DISCUSSION 
In this study, we found that some mice developed obesity whilst others were 
diet-resistant and remained lean when fed the same chronic high PA diet. There was a 
significant reduction in gut microbiota richness and diversity in the DIO mice, but not 
the DR mice. DIO mice had reduced tight junction protein expression, increased 
plasma LPS and increased inflammation in colon and liver. The gut microbiota (e.g. 
Bacteroidetes) is important for cognitive function [46]; in this study, we found that 
recognition and spatial memory were impaired in the DIO mice, with concurrent 
decreased abundance of Bacteroidetes and hippocampal BDNF mRNA expression. 
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On the other hand, the DR mice did not exhibit changes in colonic tight junction 
protein expression, levels of plasma LPS, inflammatory response in the colon and 
liver, or cognitive performance, although minor alterations in some gut microbiota at 
phylum level were observed compared to the LF controls.  
In the present study, we found that the richness (Chao1 index) of gut microbiota 
was decreased in the DIO, but not in the DR mice. This is consistent with a human 
study in which individuals with a low bacterial richness exhibited more adiposity, as 
well as insulin resistance and dyslipidaemia, and a more pronounced inflammatory 
phenotype compared to individuals with a high bacterial richness [16]. Furthermore, 
the study found that obese individuals with the lower bacterial richness also gained 
more weight over a 9 year period compared to subjects with a high bacterial richness. 
Therefore, our results, combined with the human findings[16], provide evidence that 
alterations in our second genome - the gut microbiota - may contribute to the 
heterogeneity associated with adiposity-related phenotypes. Furthermore, the diversity 
(Shannon index) of gut microbiota was decreased in the DIO mice. At the phylum 
level, the abundance of Gram-negative Bacteroidetes and Proteobacteria were 
decreased in DIO mice. Interestingly, in DR mice, the abundance of Bacteriodetes 
was also decreased, but Proteobacteria was increased compared to the LF control 
mice. LPS is a major component of the outer layer of Gram-negative bacteria and 
plasma LPS levels are closely correlated with the Gram-negative Bacteroides-like 
intestinal bacteria [47]. An elevated level of plasma LPS was previously related to the 
over-production of LPS in the gut by the death of Gram-negative bacteria and their 
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translocation into the blood circulation [47, 48]. In the present study, the plasma LPS 
increased in DIO mice, but not in DR mice, suggesting that endotoximia in obesity 
may result from the dysbiosis of Gram-negative bacteria (specifically, a decrease in 
both Bacteroidetes and Proteobacteria), while an increased proportion of 
Proteobacteria in DR mice may, to some degree, compensate for decreased levels of 
Bacteroidetes.  
Furthermore, we found that DIO mice consumed more calories. The reason of DIO 
mice consumes more calories could be due to multiple factors. It could be due altered 
regulation of gut-brain axis induced by an interaction of genetic and environment 
factors (such as high-fat diet). For example, previously we found that in DIO mice 
there is decreased gut anorexigenic peptide YY (PYY)-central neuropeptide Y (NPY) 
Y2 receptor axis, which plays an important role in promoting negative energy balance 
regulation[49]. Furthermore, Y2 receptor binding is also lowered in the hypothalamus 
in DIO mice when their body weight is similar as DR mice with energy restriction 
diet, suggesting a possible intrinsic nature of the DIO mice in response to 
high-fat diet. 
Furthermore, we found that expression of the tight junction proteins, occludin and 
ZO-1, decreased in the colon of DIO mice. The tight junction protein complex seals 
the paracellular space between epithelial cells, thus preventing paracellular diffusion 
of luminal microorganisms and their fragments, such as LPS. In the present study, 
there was a negative correlation between the levels of hyperendotoxinemia and tight 
junction proteins, occludin and ZO-1, in the colon. Furthermore, levels of 
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pro-inflammatory M1 macrophages stained with CD11c were increased in the colon 
of DIO mice without a concurrent alteration in anti-inflammatory M2 macrophage 
(CD206-positive) levels. Our finding indicates there is a shift in macrophage subtype 
to a pro-inflammatory M1 polarization in the colon of high palmitic acid diet-induced 
obesity. To our knowledge, it is firstly to report a M1 macrophage shift in the colon 
during obesity induced by high palmitic acid diet. It has been reported that 
anti-inflammatory M2 macrophages can shift into M1 macrophages to promote 
inflammation following LPS stimulation [50]. Therefore, the hyperendotoxinemia in 
DIO mice may contribute to the M1 pro-inflammatory macrophage shift in colon, in 
which most resident macrophages are normally M2 expressing CD206 to prevent 
inflammation [51]. 
TLR4 receptors are highly expressed in the colon compared to other parts of the 
intestine [18, 19]. Not only does LPS activate the TLR4 receptor, but palmitic acid 
also interacts with this receptor [52]. In the present study, TLR4 levels were elevated 
in the colon tissue of DIO mice. Therefore, an abundance of palmitic acids in the 
colon and over production of LPS from the microbiota may activate TLR4 in colon in 
the DIO mice. TLR4-MyD88-dependent pathway activates IκB-NFκBβ [20]. NFκB, a 
transcription factor, can promote the transcription of pro-inflammatory genes, such as 
IL-6 and TNFα, which in-turn can directly propagate tumorigenesis. In the colon, 
TLR4 expression is associated with adenocarcinoma and increased risk of disease 
progression. Saturated fatty acids modulate TLR4-mediated NFκB signaling pathways 
and increase COX2 [53], which plays important roles in inflammation and cancer 
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progression [47]. Epidemiological data suggest that obesity is associated with a 
30-70% increased risk of colon cancer in human [54]. Previously, we have reported 
that DIO mice develop colon polyps at a rate 2.5 times greater than the DR mice [55]. 
Therefore, activation of TLR4 and its downstream signaling pathway MyD88-NFκB 
in the colon tissue may contribute to colonic inflammation and polyp formation and 
obesity-related colon cancer. 
In the present study, the use of a novel object recognition test and exploration of a 
Y-maze demonstrated that recognition and spatial memory were impaired in 
high-palmitic acid induced obese mice (DIO), in which hippocampal BDNF levels 
were also decreased. Previous studies have highlighted a link between BDNF, 
microbiota and cognition behavior. For example, cognitive dysfunction is apparent in 
mice exhibiting altered hippocampal BDNF levels following an induced enteric 
infection, ~30 days post-inoculation [27]. Moreover, intraperitoneal administration of 
LPS in mice leads to reduced hippocampal BDNF and cognitive defects [56]. In the 
present study, alterations to gut microbiota in diet-induced obesity might be 
responsible for the observed cognition decline. We found a correlation between 
decreased Bacteroidetes and alterations in cognitive behaviors, but proof of a direct 
cause and effect mechanism is still required. Nevertheless, this correlation is further 
supported by a recent study reporting that Bacteroides in the infant gut (at 1 year of 
age) has a role in cognitive development and brain morphometry [46]. A higher 
abundance of Bacteroides at 1 year of age has been correlated with a higher cognitive 
ability (based on an overall composite score), as well as improved expressive 
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language subscale when measured again at age 2 years of age [46]. However, further 
studies on the gut microbiota-brain axis in diet-induced obesity are required. For 
example, future studies could examine cognitive behavior in normal weight, LF diet 
mice following transplantation of fecal microbiota obtained from palmitic-acid 
diet-induced obese mice, or whether supplementation of Bacteroide-rich microbiota 
can improve cognition in diet-induced obese mice. 
In conclusion, this study has showed that a diet high in obesogenic palmitic acid 
induced some mice to become obese, while others remained lean, despite being fed 
the same diet. The response in microbiota, colon and brain of diet-induced obesity 
was investigated in mice prone and resistant to obesogenic diet. The obese mice had 
decreased richness and diversity of gut microbiota, a pro-inflammatory M1 
macrophage shift and impaired tight junctions between epithelial cells of the colon, 
with an ensuing increase in plasma levels of the endotoxin, LPS. In addition, 
recognition and spatial memory were impaired in obese mice, with concurrently 
reduced hippocampal BDNF levels. Conversely, there were no significant alterations 
in colonic tight junction proteins, plasma LPS, colonic inflammation, or cognitive 
performance in mice resistant to obesity compared to lean (LF-diet) mice. Taken 
together, these data suggest that gut microbiota, colon inflammation and LPS may 
play a major role in the development of the obese phenotype and cognitive decline in 
high palmitic acid diet-induced obesity. Furthermore, this study did not examine 
microbiome prior to obesity phenotype which will be our future study.  
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Fig. 1. (A) Body weight gain, (B) final body weight, (C) energy intake, (D) fat mass, (E) 
the ratio of fat pad weight to body weight, (F) intraperitoneal glucose tolerance test, 
(G) plasma leptin, (H) plasma adiponectin, and (I) ratio of adiponectin to visceral 
(Visc.) fat in diet-induced obese (DIO), diet-resistant (DR) and low-fat (LF) diet fed 
mice. * P < .05 vs. LF. 
#
 P < .05 vs. DR. Values are mean ± SEM, n=18. 
Fig. 2. The gut microbial communities in diet-induced obese (DIO), diet-resistant (DR) 
and low-fat (LF) diet fed mice. (A) Venn diagrams comparing the OTU memberships, 
(B) richness (Chao 1 index) and diversity (Shannon index) of gut microbial 
communities based on out, (C) abundance of Firmicutes and Bacteroidetes, (D) ratio of 
Firmicutes (FM) to Bacteroidetes (BO), (E) abundance of Antinobacteria and 
Proteobacteria, (F) LEfSe results on mice gut microbiomes. Values are mean ± SEM, n 
= 6. * P < .05 vs. LF. # P < .05 vs. DR.  
Fig. 3. (A and B) Protein expression levels of occludin and zonula occludens-1 (ZO-1) in 
the colon, (C) plasma LPS levels, and correlations between plasma LPS levels and 
colonic (D) occludin or (E) ZO-1 expression in diet-induced obese (DIO), diet-resistant 
(DR) and low-fat (LF) diet fed mice. Values are mean ± SEM, n=6. * P < .05 vs. LF. # 
P < .05 vs. DR.  
Fig. 4. Inflammatory markers in the colon. (A) Immunohistochemical staining; 
percentage of (B) F4/80-, (C) CD11c- and (D) CD206-positive cells, (E and G) colonic 
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protein expression levels of TLR4, MyD88, NFκB, IκBα and p-IκBα, and (F and H) 
colonic protein expression levels of TNF-α, IL-1β, IL-6 and COX2, in diet-induced 
obese (DIO), diet-resistant (DR) and low-fat (LF) diet fed mice. Values are mean ± 
SEM, n=6. * P < .05 vs. LF. 
#
 P < .05 vs. DR. Scale bar: 80 µM. 
Fig. 5. (A) Fresh liver appearance, (B) liver weight, (C) liver weight / Body weight,  (D) 
hematoxylin and eosin staining of liver, (E) index of hepatic steatosis and cellular 
ballooning, and (F and G) protein expression levels of TLR4, MyD88 and NFκB in the 
liver of diet-induced obese (DIO), diet-resistant (DR) and low-fat (LF) diet fed mice. 
Values are mean ± SEM, n=6. * P < .05 vs. LF. # P < .05 vs. DR. Scale bar: 10 µM 
Fig. 6. (A) The ratio of time spent in novel arm in the Y maze test, (B) discrimination 
index in the novel object recognition test, and correlation between levels of gut 
Bacteroidetes and (C) ratio of time spent in the novel arm or (D) discrimination index, 
and (E and F) hippocampal BDNF mRNA levels in diet-induced obese (DIO), 
diet-resistant (DR) and low-fat (LF) diet fed mice. Values are mean ± SEM, n=12 in 
(A) and (B); n=6 in (C, D, E, F). * P < .05 vs. LF. 
#
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R = 0.65 
p = 0.003
R = 0.80
p <  0.001
